13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease

Autor: Elstein, Deborah, Abrahamov, Aya, Oz, Anat, Arbel, Naama, Baris, Hagit, Zimran, Ari
Zdroj: In Blood Cells, Molecules and Diseases December 2015 55(4):415-418
Databáze: ScienceDirect